Last updated: July 10, 2026

Application No. 19/426,722

Untitled Application

Unknown

Filed

Priority

Aug 11, 2021 — provisional 63/232,140 +2 more

Examiner

BENAVIDES, JENNIFER ANN

Art Unit

Tech Center

ImmunityBio, Inc.

Assignee

ImmunityBio Inc.

OA Round

1 (Non-Final)

This examiner grants 51% of cases after interview

— +48.0% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 116 resolved cases, 2023–2026

Examiner Intelligence

BENAVIDES, JENNIFER ANN View full profile →

Grants 51% of resolved cases

Career Allowance Rate

59 granted / 116 resolved

-9.1% vs TC avg

Strong +48% interview lift

Without

With

+48.0%

Interview Lift

resolved cases with interview

Typical timeline

3y 2m

Avg Prosecution

43 currently pending

Career history

157

Total Applications

across all art units

Statute-Specific Performance

§101

0.5%

-39.5% vs TC avg

§103

43.3%

+3.3% vs TC avg

§102

10.0%

-30.0% vs TC avg

§112

19.9%

-20.1% vs TC avg

Black line = Tech Center average estimate • Based on career data from 116 resolved cases

Prosecution Timeline

May 05, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

18/417,708

Patent 12612463

MESOTHELIN-TARGETED CD40 AGONISTIC MULTISPECIFIC ANTIBODY CONSTRUCTS FOR THE TREATMENT OF SOLID TUMORS

2y 3m to grant Granted Apr 28, 2026

17/759,800

Patent 12596122

NOVEL LILRB2 ANTIBODIES AND USES THEREOF

3y 8m to grant Granted Apr 07, 2026

17/775,167

Patent 12595310

COMPOSITIONS AND METHODS FOR TRANSFERRIN RECEPTOR 1 TARGETING

3y 11m to grant Granted Apr 07, 2026

18/423,089

Patent 12582713

METHODS OF TREATING TUMORS

2y 1m to grant Granted Mar 24, 2026

17/642,674

Patent 12570725

ZIKA ANTIBODIES AND THEIR USE

4y 0m to grant Granted Mar 10, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

51%

Grant Probability

99%

With Interview (+48.0%)

3y 2m

Median Time to Grant

Low

PTA Risk

Based on 116 resolved cases by this examiner. Grant probability derived from career allowance rate.